Physician profile
Larry Ray
NPI 1831257054
$3,282.54
in general payments reported to CMS, 2019-2025
17 companies · $600 in 2025
The $600 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $931 · 2020: $120 · 2021: $100 · 2022: $320 · 2023: $545 · 2024: $667 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,811.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $500.00 | 2023-2025 | Auvelity, Sunosi |
| Alkermes, INC. | $467.33 | 2019-2025 | Lybalvi |
| Vanda Pharmaceuticals INC. | $251.50 | 2024-2025 | Fanapt |
| Neurocrine Biosciences, INC. | $244.27 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $227.32 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $213.75 | 2019-2023 | Uzedy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $202.44 | 2023-2025 | Caplyta |
| Abbvie INC. | $202.27 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $172.08 | 2019 | |
| Acadia Pharmaceuticals INC | $125.00 | 2024 | Nuplazid |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2025 | Cobenfy |
| Mdd US Operations, LLC | $125.00 | 2019 | |
| Validus Pharmaceuticals LLC | $120.00 | 2019 | |
| Biogen, INC. | $100.00 | 2024 | Zurzuvae |
| Tris Pharma INC | $98.81 | 2023 | Dyanavel Xr, Quillichew Er, Quillivant |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $86.95 | 2019 | |
| Indivior INC. | $20.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.